Drug intelligence / Profile preview

BCG vaccine + measles vaccine

Development stage
Unknown
Lead developer
Bandim Health Project
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal, Subcutaneous
01

Overview

This refers to the combined or sequential administration of the **BCG (Bacillus Calmette-Guérin)** vaccine and the **measles vaccine** as evaluated in the **MATVAC (Maternal and Infant BCG and Measles Vaccination Study)**. Conducted by the **Bandim Health Project** in Guinea-Bissau, this phase 4 factorial randomized controlled trial investigates the **non-specific effects (NSE)** of these live attenuated vaccines. While BCG is traditionally used for tuberculosis and the measles vaccine for measles, research suggests these vaccines can strengthen the immune system against a broad range of unrelated infectious diseases through a process known as **trained immunity**. The MATVAC study specifically explores whether vaccinating mothers with these live vaccines can enhance the health, immunity, and survival of both the mothers and their infants.

Other names
Maternal BCG and Measles VaccinationBCG and Measles vaccine combinationMaternal and Infant BCG and Measles Vaccination Study

Beyond the preview

Go deeper on BCG vaccine + measles vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCG vaccine + measles vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call